(20 ILCS 2310/2310-395)
(was 20 ILCS 2310/55.72)
Task Force on Organ Transplantation.
(a) There is established within the Department a Task
on Organ Transplantation ("the Task Force"). The Task Force shall have the
following 21 members:
(1) The Director, ex officio, or his or her designee.
(2) The Secretary of State, ex officio, or his or her
(3) Four members, appointed one each by the President
of the Senate, the Minority Leader of the Senate, the Speaker of the House of Representatives, and the Minority Leader of the House of Representatives.
(4) Fifteen members appointed by the Director as
follows: 2 physicians (at least one of whom shall have experience in organ transplantation); one representative of medical schools; one representative of hospitals; one representative of insurers or self-insurers; one representative of an organization devoted to organ donation or the coordination of organ donations; one representative of an organization that deals with tissue donation or the coordination of tissue donations; one representative from the Department of Healthcare and Family Services; one representative from the Illinois Eye Bank Community; one representative from the Illinois Hospital and Health Systems Association; one representative from the Illinois State Coroners Association; one representative from the Illinois State Medical Society; one representative from Mid-America Transplantation Services; and 2 members of the general public who are knowledgeable in areas of the Task Force's work.
(b) The Task Force shall conduct a comprehensive examination of the medical,
legal, ethical, economic, and social issues presented by human organ
procurement and transplantation.
(c) The Task Force shall report its findings and recommendations to the
Governor and the General Assembly on or before January 1, of each year, and
the Task Force's final report shall be filed on or before January 1, 1999. The
shall include, but need not be limited to, the following:
(1) An assessment of public and private efforts to
procure human organs for transplantation and an identification of factors that diminish the number of organs available for transplantation.
(2) An assessment of problems in coordinating the
procurement of viable human organs and tissue including skin and bones.
(3) Recommendations for the education and training of
health professionals, including physicians, nurses, and hospital and emergency care personnel, with respect to organ procurement.
(4) Recommendations for the education of the general
public, the clergy, law enforcement officers, members of local fire departments, and other agencies and individuals that may be instrumental in affecting organ procurement.
(5) Recommendations for ensuring equitable access by
patients to organ transplantation and for ensuring the equitable allocation of donated organs among transplant centers and among patients medically qualified for an organ transplant.
(6) An identification of barriers to the donation of
organs to patients (with special emphasis on pediatric patients), including an assessment of each of the following:
(A) Barriers to the improved identification of
organ donors and their families and organ recipients.
(B) The number of potential organ donors and
their geographical distribution.
(C) Current health care services provided for
patients who need organ transplantation and organ procurement procedures, systems, and programs that affect those patients.
(D) Cultural factors affecting the facility with
respect to the donation of the organs.
(E) Ethical and economic issues relating to organ
transplantation needed by chronically ill patients.
(7) An analysis of the factors involved in insurance
reimbursement for transplant procedures by private insurers and the public sector.
(8) An analysis of the manner in which organ
transplantation technology is diffused among and adopted by qualified medical centers, including a specification of the number and geographical distribution of qualified medical centers using that technology and an assessment of whether the number of centers using that technology is sufficient or excessive and whether the public has sufficient access to medical procedures using that technology.
(9) Recommendations for legislative changes necessary
to make organ transplants more readily available to Illinois citizens.
(d) The Director of Public Health shall review the progress of the Task
Force to determine the need for its continuance, and the Director shall report
this determination to the Governor and the General Assembly on or before
January 1, 1999.
(Source: P.A. 95-331, eff. 8-21-07.)